Valuation: Azenta, Inc.

Market Cap 1.17B 1.03B 946M 869M 1.65B 113B 1.68B 11.29B 4.43B 55.15B 4.4B 4.31B 190B P/E 2026 *
-6.95x
P/E 2027 * 106x
Enterprise Value 1.17B 1.03B 946M 869M 1.65B 113B 1.68B 11.29B 4.43B 55.15B 4.4B 4.31B 190B EV / Sales 2026 *
1.95x
EV / Sales 2027 * 1.86x
Free-Float
76.62%
Yield 2026 *
-
Yield 2027 * -
1 day+3.68%
1 week+7.87%
Current month+3.61%
1 month+15.21%
3 months+5.97%
6 months-33.75%
Current year-20.51%
1 week 24.46
Extreme 24.455
26.63
1 month 21.99
Extreme 21.99
27.05
Current year 15.93
Extreme 15.93
41.73
1 year 15.93
Extreme 15.93
41.73
3 years 15.93
Extreme 15.93
69.16
5 years 15.93
Extreme 15.93
124.79
10 years 12.05
Extreme 12.05
124.79
Manager TitleAgeSince
Chief Executive Officer 45 2024-09-08
Director of Finance/CFO 49 2024-11-30
Chief Tech/Sci/R&D Officer - 2009-10-31
Director TitleAgeSince
Director/Board Member 64 2013-06-27
Director/Board Member 50 2020-04-02
Chairman 72 2024-01-29
Date Insider Type Main position Quantity % Market Cap.
05-17Buy

Director

10,000 0.0217%
05-14Tax

General Counsel

-3,621 0.0079%
04-27Free

President Multiomics

17,790 0.0386%
Change 5-day change 1-year change 3-year change Capi.($)
+3.77%+7.87%-17.14%-41.23% 1.17B
-0.17%+1.47%+3.16%+7.43% 50.35B
-0.68%-2.99%+386.91%+591.85% 39.32B
+0.24%+2.68%+32.70%-5.48% 34.69B
+1.05%+3.31%+15.64%+57.59% 34.08B
+1.68%-1.40%+4.23%+27.34% 26.63B
-0.14%-4.52% - - 16.49B
-0.64%+0.32%+70.66%+115.75% 15.31B
+0.43%+3.34%+14.96%+17.98% 13.8B
+0.29%+1.79%+15.70%-31.26% 12.87B
Average +0.59%-0.34%+58.53%+82.22% 24.47B
Weighted average by Cap. +0.24%-0.31%+81.61%+121.46%

Financials

2026 *2027 *
Net sales 600M 525M 484M 445M 844M 57.78B 858M 5.78B 2.27B 28.24B 2.25B 2.21B 97.33B 630M 550M 508M 467M 884M 60.57B 899M 6.06B 2.38B 29.61B 2.36B 2.31B 102B
Net income -159M -139M -128M -118M -224M -15.32B -227M -1.53B -601M -7.49B -598M -585M -25.8B 17.3M 15.13M 13.95M 12.83M 24.3M 1.66B 24.72M 167M 65.36M 814M 64.97M 63.54M 2.8B
Net Debt - -
Logo Azenta, Inc.
Azenta, Inc. is a global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company develops solutions for automated ultra-cold storage. It operates through two segments, which include Sample Management Solutions and Multiomics. The Sample Management Solutions segment operates as a single business unit offering end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Multiomics segment operates as a single business unit offering genomic and other sample analysis services, including gene sequencing, gene synthesis and related services. It offers a portfolio of products and sample services including procurement, automated storage systems, genomic services and a multitude of sample consumables, informatics and data software.
Employees
2,900
Date Price Change Volume
26-07-15 US$26.37 +3.66% 150,835
26-07-14 US$25.44 -2.34% 880,376
26-07-13 US$26.05 +2.72% 575,286
26-07-10 US$25.36 -0.24% 544,665
26-07-09 US$25.42 +3.71% 591,983
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
25.44USD
Average target price
26.20USD
Spread / Average Target
+2.99%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AZTA Stock